Exane BNP Paribas Reaffirms Outperform Rating on Reed Elsevier (REL)
Reed Elsevier (LON: REL)‘s stock had its “outperform” rating restated by equities researchers at Exane BNP Paribas in a report issued on Monday. They currently have a $11.26 (700 GBX) target price on the stock.
Reed Elsevier opened at 600.50 on Monday. Reed Elsevier has a 52-week low of GBX 466.10 and a 52-week high of GBX 671.21. The company’s market cap is £7.231 billion.
A number of other analysts have also recently weighed in on REL. Analysts at Liberum Capital Ltd reiterated a “buy” rating on shares of Reed Elsevier in a research note to investors on Wednesday, October 24th. They now have a $11.16 price target on the stock. Separately, analysts at Investec reiterated a “buy” rating on shares of Reed Elsevier in a research note to investors on Monday, October 8th. They now have a $11.70 price target on the stock.
Reed Elsevier PLC is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.